European Pharmaceutical Review Issue 3 2025
By European Pharmaceutical Review
Novartis builds on Monte Rosa collaboration with $5.7 billion deal
By Catherine Eckford (European Pharmaceutical Review)
CPHI Frankfurt 2025 prepares to open its doors
By Dominic Tyer (European Pharmaceutical Review)
Demand for AI-integration propelling mass spectrometry growth
By Catherine Eckford (European Pharmaceutical Review)
Simplified rAAV lysate purification for complex analytics of upstream samples
By Marko Narobe (Sartorius Biosepartions), Michael Gerrero (BridgeBio), Srivatsan Ramesh…